Deal Announcements

Apoptos Raises $28 Million Series A Funding

Wednesday, May 07, 2008 5:41:00 AM PDT | VentureDeal Staff

SAN DIEGO, CA -- Pharmaceutical company Apoptos, Inc. announced the close of its series A round of venture capital financing, receiving $28 million.

The company is developing small molecule drugs that directly induce tumor cell apoptosis, or programmed cell death.

Investors in the round included Venrock, ARCH Venture Partners, OrbiMed Advisors and Advanced Technology Ventures.  Funding proceeds will be used to advance its line of candidates.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1